LONDON, GREATER LONDON, UK, September 6, 2023/EINPresswire.com/ -- The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032
The Business Research Company’s “Gastroesophageal Reflux Disease Therapeutics Global Market Report 2023” is a comprehensive source of information that covers every facet of the market. As per TBRC’s market forecast, the gastroesophageal reflux disease therapeutics market size is predicted to reach $6.82 billion in 2027 at a CAGR of 4.2%.
The growth in the gastroesophageal reflux disease therapeutics market is due to prevalence of gastroesophageal reflux disease. North America region is expected to hold the largest gastroesophageal reflux disease therapeutics market share. Major players in the gastroesophageal reflux disease therapeutics market include Pfizer Inc., Johnson and Johnson, Novartis AG, Sanofi S.A., AstraZeneca plc, Medtronic PLC.
Gastroesophageal Reflux Disease Therapeutics Market Segments
• By Type: Branded, Generic
• By Drug Class: Antacids, Proton Pump Inhibitors, Histamine Blockers, Pro-Kinetic Agents, Other Drugs Class
• By Distribution Channel: Hospital Pharmacy, Drug Stores, General Stores, Supermarkets
• By Application: Crohn’s Disease, Gastroesophageal Reflux Disease (GERD), Ulcerative Colitis
• By Geography: The gastroesophageal reflux disease therapeutics global market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa.
Learn More On The Market By Requesting A Free Sample (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/report/gastroesophageal-reflux-disease-therapeutics-global-market-report
Gastroesophageal reflux disease (GERD) therapeutics is a medication for chronic medical illness characterized by the upward movement of stomach contents into the esophagus that causes heartburn and regurgitation. The therapeutics are used to neutralize and reduce the production of stomach acid to maintain optimal pH in the gut and prevent the passage of fluids back into the stomach that cause acid reflux.
Read More On The Gastroesophageal Reflux Disease Therapeutics Global Market Report At:
https://www.thebusinessresearchcompany.com/report/gastroesophageal-reflux-disease-therapeutics-global-market-report
The Table Of Content For The Market Report Include:
1. Executive Summary
2. Market Characteristics
3. Gastroesophageal Reflux Disease Therapeutics Market Trends And Strategies
4. Gastroesophageal Reflux Disease Therapeutics Market – Macro Economic Scenario
5. Market Size And Growth
……
27. Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions In The Market
29. Market Future Outlook and Potential Analysis
30. Appendix
Browse Through More Similar Reports By The Business Research Company:
Proton Pump Inhibitors Global Market Report 2023
https://www.thebusinessresearchcompany.com/report/proton-pump-inhibitors-global-market-report
Antacids Global Market Report 2023
https://www.thebusinessresearchcompany.com/report/antacids-global-market-report
Enzyme Inhibitor Global Market Report 2023
https://www.thebusinessresearchcompany.com/report/enzyme-inhibitor-global-market-report
Contact Information
The Business Research Company: https://www.thebusinessresearchcompany.com/
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: [email protected]
Check out our:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Oliver Guirdham
The Business Research Company
+44 20 7193 0708
[email protected]
Visit us on social media:
Facebook
Twitter
LinkedIn
